1. Home
  2. AYTU vs EFOI Comparison

AYTU vs EFOI Comparison

Compare AYTU & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • EFOI
  • Stock Information
  • Founded
  • AYTU N/A
  • EFOI 1985
  • Country
  • AYTU United States
  • EFOI United States
  • Employees
  • AYTU N/A
  • EFOI N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • EFOI Building Products
  • Sector
  • AYTU Health Care
  • EFOI Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • EFOI Nasdaq
  • Market Cap
  • AYTU 9.6M
  • EFOI 12.1M
  • IPO Year
  • AYTU N/A
  • EFOI 1994
  • Fundamental
  • Price
  • AYTU $2.21
  • EFOI $2.40
  • Analyst Decision
  • AYTU Strong Buy
  • EFOI
  • Analyst Count
  • AYTU 2
  • EFOI 0
  • Target Price
  • AYTU $10.00
  • EFOI N/A
  • AVG Volume (30 Days)
  • AYTU 663.3K
  • EFOI 21.9K
  • Earning Date
  • AYTU 05-14-2025
  • EFOI 08-12-2025
  • Dividend Yield
  • AYTU N/A
  • EFOI N/A
  • EPS Growth
  • AYTU N/A
  • EFOI N/A
  • EPS
  • AYTU N/A
  • EFOI N/A
  • Revenue
  • AYTU $81,659,000.00
  • EFOI $4,643,000.00
  • Revenue This Year
  • AYTU N/A
  • EFOI N/A
  • Revenue Next Year
  • AYTU $8.68
  • EFOI N/A
  • P/E Ratio
  • AYTU N/A
  • EFOI N/A
  • Revenue Growth
  • AYTU 0.41
  • EFOI N/A
  • 52 Week Low
  • AYTU $0.95
  • EFOI $1.14
  • 52 Week High
  • AYTU $2.96
  • EFOI $2.95
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 63.18
  • EFOI 61.50
  • Support Level
  • AYTU $2.04
  • EFOI $1.64
  • Resistance Level
  • AYTU $2.40
  • EFOI $2.48
  • Average True Range (ATR)
  • AYTU 0.14
  • EFOI 0.20
  • MACD
  • AYTU 0.00
  • EFOI 0.05
  • Stochastic Oscillator
  • AYTU 54.90
  • EFOI 81.13

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About EFOI Energy Focus Inc.

Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.

Share on Social Networks: